Without a specific headline event, Altria Group (MO) has recently drawn attention as investors weigh its current share price of $64.32 in relation to recent returns and the business mix across smokeable, oral tobacco and e-vapor products.
See our latest analysis for Altria Group.
While the share price has eased in the short term, with a 7 day share price return of 4% and a 30 day share price return of 4.8%, the 90 day share price return of 9.1% and 1 year total shareholder return of 21.4% point to momentum that has rewarded patient holders over multi year periods.
If you are weighing Altria against other ideas, this could be a good moment to broaden your watchlist with 20 top founder-led companies
With the shares trading at $64.32, only 1.8% below one set of analyst targets but showing a reported 37% intrinsic discount, you have to ask: is this a genuine value gap, or is the market already pricing in future growth?
Most Popular Narrative: 1.8% Undervalued
Altria's widely followed narrative anchors fair value at $65.50, just above the last close at $64.32. This puts the focus firmly on earnings resilience and margin assumptions behind that target.
The analysts have a consensus price target of $65.5 for Altria Group based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $74.0, and the most bearish reporting a price target of just $50.0.
Want to understand why this narrative leans on rising profitability even as revenue assumptions stay muted? The key ingredients mix stable sales, richer margins and a lower future earnings multiple than many peers assume. Curious which moving parts matter most for that $65.50 fair value and how tightly they are calibrated?
Result: Fair Value of $65.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the picture could change quickly if illicit e vapor products continue to weigh on NJOY, or if ongoing legal actions around Juul reshape expectations for future profits.
Find out about the key risks to this Altria Group narrative.
Next Steps
The mix of risks and rewards around Altria will not stay static, so it helps to review the numbers yourself and move with intent. To round out your view before making any decisions, weigh up the 2 key rewards and 5 important warning signs.
Looking for more investment ideas?
If you stop with just one stock, you miss chances to match ideas with your goals, so keep expanding your watchlist and stay ready when conditions shift.
- Target reliable income by scanning for companies that meet your yield and stability preferences through the 13 dividend fortresses.
- Hunt for value by checking stocks that pair solid fundamentals with attractive prices using the 58 high quality undervalued stocks.
- Prioritise resilience by focusing on companies with healthier financial profiles via the 73 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com